ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations
Diane
The post ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0 , therapy for stage 4 NSCLC without driver alterations appeared first on ECOG-ACRIN Cancer Research Group .